Localization of transfused neutrophils to site of infection during treatment with recombinant human granulocyte-macrophage colony-stimulating factor and pentoxifylline.
Montgomery
B
B
Bianco
J A
JA
Jacobsen
A
A
Singer
J W
JW
D000038:Abscess / Q000473:pathology / Q000628:therapy*; D000328:Adult; D001803:Blood Transfusion; D016026:Bone Marrow Transplantation; D002177:Candidiasis / Q000473:pathology / Q000628:therapy*; D016178:Granulocyte-Macrophage Colony-Stimulating Factor / Q000627:therapeutic use*; D006689:Hodgkin Disease / Q000473:pathology / Q000628:therapy*; D006801:Humans; D008297:Male; D009504:Neutrophils / Q000502:physiology*; D010431:Pentoxifylline / Q000627:therapeutic use*; D011994:Recombinant Proteins / Q000627:therapeutic use; D012871:Skin Diseases / Q000473:pathology / Q000628:therapy*
D011994:Recombinant Proteins; D016178:Granulocyte-Macrophage Colony-Stimulating Factor; D010431:Pentoxifylline